Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Induction of Fibrosis Regression on Patients With Chronic Hepatitis B Infection (INFIRE)

This study has been terminated.
(insufficient patient numbers have been recruited)
Sponsor:
Collaborators:
Hannover Medical School
Hannover Clinical Trial Center GmbH
Information provided by (Responsible Party):
RWTH Aachen University
ClinicalTrials.gov Identifier:
NCT01341106
First received: April 20, 2011
Last updated: September 22, 2015
Last verified: September 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2015
  Primary Completion Date: January 2015 (Final data collection date for primary outcome measure)